BAFF/IL-17 Bispecific Antibody Treatment in Subjects With Primary Sjogren's Syndrome

Clinical trial NCT04563195 · WITHDRAWN

Trial details

NCT number: NCT04563195
Sponsor: Matthew C. Baker
Status: WITHDRAWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Primary Sjogren's Syndrome

Start date: 2022-02-01
Primary completion: 2023-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.